Clorox Company (The) (CLX) Stock Rating Reaffirmed by BMO Capital Markets

BMO Capital Markets reiterated their outperform rating on shares of Clorox Company (The) (NYSE:CLX) in a research note published on Tuesday, September 12th.

Other equities analysts have also recently issued research reports about the company. Jefferies Group LLC reiterated a hold rating and issued a $137.00 target price (up previously from $136.00) on shares of Clorox Company (The) in a report on Wednesday, August 9th. Royal Bank Of Canada reiterated a hold rating and issued a $115.00 target price on shares of Clorox Company (The) in a report on Wednesday, August 2nd. BidaskClub upgraded Clorox Company (The) from a strong sell rating to a sell rating in a report on Monday, July 31st. Zacks Investment Research cut Clorox Company (The) from a buy rating to a hold rating in a report on Monday, July 31st. Finally, Barclays PLC reiterated an equal weight rating and issued a $136.00 target price (down previously from $140.00) on shares of Clorox Company (The) in a report on Friday, August 4th. Two research analysts have rated the stock with a sell rating, ten have given a hold rating and two have issued a buy rating to the stock. The stock presently has a consensus rating of Hold and a consensus target price of $127.81.

Clorox Company (NYSE:CLX) opened at 129.33 on Tuesday. The firm has a market capitalization of $16.69 billion, a P/E ratio of 24.24 and a beta of 0.40. The company has a 50 day moving average of $136.15 and a 200 day moving average of $135.22. Clorox Company has a 1-year low of $111.24 and a 1-year high of $141.76.

Clorox Company (The) (NYSE:CLX) last released its quarterly earnings data on Thursday, August 3rd. The company reported $1.53 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.49 by $0.04. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. The business had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.65 billion. During the same quarter in the previous year, the company posted $1.30 EPS. The company’s revenue was up 2.9% compared to the same quarter last year. On average, equities research analysts anticipate that Clorox Company will post $5.66 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: This report was first reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this report on another site, it was stolen and reposted in violation of international copyright & trademark law. The original version of this report can be read at https://www.dispatchtribunal.com/2017/09/28/clorox-company-the-clx-given-outperform-rating-at-bmo-capital-markets.html.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 13th. Investors of record on Wednesday, October 25th will be issued a dividend of $0.84 per share. This represents a $3.36 dividend on an annualized basis and a yield of 2.62%. The ex-dividend date of this dividend is Tuesday, October 24th. Clorox Company (The)’s payout ratio is currently 63.04%.

In other Clorox Company (The) news, SVP Jon M. Balousek sold 9,223 shares of Clorox Company (The) stock in a transaction on Wednesday, August 23rd. The stock was sold at an average price of $138.87, for a total transaction of $1,280,798.01. Following the completion of the sale, the senior vice president now directly owns 20,614 shares of the company’s stock, valued at approximately $2,862,666.18. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP James E. Foster sold 9,861 shares of Clorox Company (The) stock in a transaction on Wednesday, August 23rd. The shares were sold at an average price of $138.51, for a total value of $1,365,847.11. Following the sale, the executive vice president now directly owns 22,069 shares of the company’s stock, valued at $3,056,777.19. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 21,242 shares of company stock valued at $2,944,449. 0.74% of the stock is currently owned by corporate insiders.

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. American Beacon Advisors Inc. bought a new position in shares of Clorox Company (The) in the 1st quarter worth $104,000. Parkside Financial Bank & Trust raised its position in shares of Clorox Company (The) by 3.8% in the 2nd quarter. Parkside Financial Bank & Trust now owns 796 shares of the company’s stock worth $107,000 after acquiring an additional 29 shares in the last quarter. Valley National Advisers Inc. raised its position in shares of Clorox Company (The) by 0.6% in the 2nd quarter. Valley National Advisers Inc. now owns 865 shares of the company’s stock worth $115,000 after acquiring an additional 5 shares in the last quarter. Blue Chip Partners Inc. raised its position in shares of Clorox Company (The) by 0.7% in the 1st quarter. Blue Chip Partners Inc. now owns 906 shares of the company’s stock worth $122,000 after acquiring an additional 6 shares in the last quarter. Finally, Sun Life Financial INC raised its position in shares of Clorox Company (The) by 10,344.4% in the 2nd quarter. Sun Life Financial INC now owns 940 shares of the company’s stock worth $125,000 after acquiring an additional 931 shares in the last quarter. 71.24% of the stock is owned by hedge funds and other institutional investors.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Analyst Recommendations for Clorox Company (The) (NYSE:CLX)




Receive News & Ratings for Clorox Company (The) Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Clorox Company (The) and related companies with MarketBeat.com’s FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

eighteen − one =